Clinical Trial Update: Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a safety and efficacy study of Ulocuplumab with Nivolumab in solid tumors; trial terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Ulocuplumab (ulocuplumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-03-29